EXR
19
-21
IBM
40
-10
HP
18
-10
AMZN
38
-3
HRL
32
-9
TSN
40
-15
PEG
36
-14
HPQ
34
-4
GILD
60
-9
ADT
58
-3
GOOGL
20
-15
AKAM
21
-6
ROP
42
-15
BK
43
-15
RRC
43
-16
VMC
45
-8
D
19
-14
AMP
37
-6
OMC
39
-5
T
51
-17
EXR
19
-21
IBM
40
-10
HP
18
-10
AMZN
38
-3
HRL
32
-9
TSN
40
-15
PEG
36
-14
HPQ
34
-4
GILD
60
-9
ADT
58
-3
GOOGL
20
-15
AKAM
21
-6
ROP
42
-15
BK
43
-15
RRC
43
-16
VMC
45
-8
D
19
-14
AMP
37
-6
OMC
39
-5
T
51
-17
Financhill
Back

Recursion Pharmaceuticals 10K Form

Sell
1

RXRX
Recursion Pharmaceuticals

Last Price:
$4.21
Seasonality Move:
0.33%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive RXRX News And Ratings

See the #1 stock for the next 7 days that we like better than RXRX

RXRX Financial Statistics

Sales & Book Value

Annual Sales: $58.5M
Cash Flow: $-117.1M
Price / Cash Flow: 0
Annual Sales: $2.61
Price / Book: 1.65

Profitability

EPS (TTM): -1.66000
Net Income (TTM): $-463.7M
Gross Margin: $13.3M
Return on Equity: -77.06%
Return on Assets: -55.7%

Recursion Pharmaceuticals Earnings Forecast

Key Recursion Pharmaceuticals Financial Ratios

  • The Gross Profit Margin over the past 5 years for RXRX is 22.65%.
  • The Selling, General & Administrative Expenses for RXRX have been equal to 304.65% of Gross Profit Margin.
  • The Research & Development expenses have been 537.58% of Revenue.
  • The Net Earning history of RXRX is -792.75% of Total Revenues.
  • Per Share Earnings over the last 6 years have been positive in 1 years.

Recursion Pharmaceuticals Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: NASDAQ
Industry: Biotechnology
Sector: Health Care
Current Symbol: RXRX
Website: recursion.com

Debt

Debt-to-Equity Ratio: 0.03
Current Ratio: 3.81
Quick Ratio: 3.43

Price-to-Earnings

Trailing P/E Ratio: 0
Forward P/E Ratio: 0

RXRX Technical Analysis vs Fundamental Analysis

Sell
1
Recursion Pharmaceuticals (RXRX) is a Sell

Is Recursion Pharmaceuticals a Buy or a Sell?